Literature DB >> 12871670

Phosphoinositide 3-kinase signalling--which way to target?

Matthias P Wymann1, Marketa Zvelebil, Muriel Laffargue.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12871670     DOI： 10.1016/S0165-6147(03)00163-9

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN： 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  107 in total

1.  Interaction of Chlamydia trachomatis serovar L2 with the host autophagic pathway.

Authors:  Hesham M Al-Younes; Volker Brinkmann; Thomas F Meyer
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

2.  Biased binding of class IA phosphatidyl inositol 3-kinase subunits to inducible costimulator (CD278).

Authors:  Yenny Y Acosta; Maria Paz Zafra; Gloria Ojeda; Ilaria Seren Bernardone; Umberto Dianzani; Pilar Portolés; Jose M Rojo
Journal:  Cell Mol Life Sci       Date:  2010-12-28       Impact factor: 9.261

3.  Cancer-specific mutations in PIK3CA are oncogenic in vivo.

Authors:  Andreas G Bader; Sohye Kang; Peter K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

4.  Oncogenic transformation induced by the p110beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase.

Authors:  Sohye Kang; Adam Denley; Bart Vanhaesebroeck; Peter K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

5.  Pathway-specific effect of caffeine on protection against UV irradiation-induced apoptosis in corneal epithelial cells.

Authors:  Ling Wang; Luo Lu
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-02       Impact factor: 4.799

6.  FKBP5 genetic variation: association with selective serotonin reuptake inhibitor treatment outcomes in major depressive disorder.

Authors:  Katarzyna A Ellsworth; Irene Moon; Bruce W Eckloff; Brooke L Fridley; Gregory D Jenkins; Anthony Batzler; Joanna M Biernacka; Ryan Abo; Abra Brisbin; Yuan Ji; Scott Hebbring; Eric D Wieben; David A Mrazek; Richard M Weinshilboum; Liewei Wang
Journal:  Pharmacogenet Genomics       Date:  2013-03       Impact factor: 2.089

7.  MicroRNA-10a controls airway smooth muscle cell proliferation via direct targeting of the PI3 kinase pathway.

Authors:  Ruoxi Hu; Wenchi Pan; Alexey V Fedulov; William Jester; Matthew R Jones; Scott T Weiss; Reynold A Panettieri; Kelan Tantisira; Quan Lu
Journal:  FASEB J       Date:  2014-02-12       Impact factor: 5.191

8.  Sjögren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase.

Authors:  Jean S Oak; Jonathan A Deane; Michael G Kharas; Ji Luo; Thomas E Lane; Lewis C Cantley; David A Fruman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-27       Impact factor: 11.205

Review 9.  The Role of PI3K/Akt and ERK in Neurodegenerative Disorders.

Authors:  Sachchida Nand Rai; Hagera Dilnashin; Hareram Birla; Saumitra Sen Singh; Walia Zahra; Aaina Singh Rathore; Brijesh Kumar Singh; Surya Pratap Singh
Journal:  Neurotox Res       Date:  2019-02-01       Impact factor: 3.911

10.  SB365 inhibits angiogenesis and induces apoptosis of hepatocellular carcinoma through modulation of PI3K/Akt/mTOR signaling pathway.

Authors:  Sang-Won Hong; Kyung Hee Jung; Hee-Seung Lee; Myung-Joo Choi; Mi Kwon Son; Hong-Mei Zheng; Soon-Sun Hong
Journal:  Cancer Sci       Date:  2012-09-25       Impact factor: 6.716
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.